Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1 to 15 of 8162 results

  1. Epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer

    In development [GID-IPG10291] Expected publication date: 02 April 2024

  2. Kurin Lock for blood culture collection

    In development [GID-MT582] Expected publication date: 03 April 2024

  3. Dostarlimab with platinum-based chemotherapy for treating advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency [ID3968]

    In development [GID-TA10850] Expected publication date: 03 April 2024

  4. GID-MT575 GaitSmart rehabilitation exercise programme for gait and mobility issues

    In development [GID-MT575] Expected publication date: 03 April 2024

  5. Twin and triplet pregnancy - progesterone for preventing preterm birth

    In development [GID-NG10383] Expected publication date: 09 April 2024

  6. Asthma: diagnosis, monitoring and chronic asthma management

    In development [GID-NG10186] Expected publication date: 30 October 2024

  7. Cabozantinib with nivolumab for untreated advanced renal cell carcinoma [ID6184]

    In development [GID-TA11158] Expected publication date: 10 April 2024

  8. Lymphovenous anastomosis at the time of axillary/inguinal lymph node dissection for the prevention of secondary lymphoedema

    In development [GID-IPG10263] Expected publication date: 16 April 2024

  9. Endometriosis: diagnosis and management - surgical management if fertility is a priority

    In development [GID-NG10393] Expected publication date: 16 April 2024

  10. Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas (CG118)

    This guideline covers using colonoscopy to check for signs of bowel cancer in people aged 18 and over with ulcerative colitis or Crohn’s disease (types of inflammatory bowel disease) or adenomas (also known as polyps). It aims to prevent cancer and prolong life by offering advice on identifying early bowel cancer in adults most at risk.

  11. Suspected neurological conditions: recognition and referral (NG127)

    This guideline covers the initial assessment of symptoms and signs that might indicate a neurological condition. It helps non-specialist healthcare professionals to identify people who should be offered referral for specialist investigation.

  12. Hepatitis B (chronic): diagnosis and management (CG165)

    This guideline covers assessing and managing chronic hepatitis B in children, young people and adults. It aims to improve care for people with hepatitis B by specifying which tests and treatments to use for people of different ages and with different disease severities.

  13. Varicose veins: diagnosis and management (CG168)

    This guideline covers diagnosing and managing varicose veins in people aged 18 and over. It aims to ensure that people understand the options for treating varicose veins and that healthcare professionals know when to refer people for specialist assessment and treatment.

  14. Autism spectrum disorder in under 19s: support and management (CG170)

    This guideline covers children and young people with autism spectrum disorder (across the full range of intellectual ability) from birth until their 19th birthday. It covers the different ways that health and social care professionals can provide support, treatment and help for children and young people with autism, and their families and carers, from the early years through to their transition into young adult life.

  15. Dental checks: intervals between oral health reviews (CG19)

    This guideline covers assigning recall intervals between oral health reviews that are appropriate to the needs of individual patients. The guideline takes account of the effect of dental checks on: people’s wellbeing, general health and preventive habits; caries incidence and avoiding restorations; periodontal health and avoiding tooth loss; and avoiding pain and anxiety. It aims to improve or maintain patients’ quality of life and reduce morbidity associated with oral and dental disease.